Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease

Abstract Rheumatoid arthritis (RA) is an inflammatory autoimmune disease, and RA interstitial lung disease (ILD) is a severe complication of RA. This investigation aims to determine the effect and underlying mechanism of osthole (OS), which could be extracted from Cnidium, Angelica, and Citrus plant...

Full description

Saved in:
Bibliographic Details
Main Authors: Xian Lin, Jian Chen, Cheng Tao, Lianxiang Luo, Juan He, Qingwen Wang
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.219
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589924994383872
author Xian Lin
Jian Chen
Cheng Tao
Lianxiang Luo
Juan He
Qingwen Wang
author_facet Xian Lin
Jian Chen
Cheng Tao
Lianxiang Luo
Juan He
Qingwen Wang
author_sort Xian Lin
collection DOAJ
description Abstract Rheumatoid arthritis (RA) is an inflammatory autoimmune disease, and RA interstitial lung disease (ILD) is a severe complication of RA. This investigation aims to determine the effect and underlying mechanism of osthole (OS), which could be extracted from Cnidium, Angelica, and Citrus plants and evaluate the role of transglutaminase 2 (TGM2) in RA and RA‐ILD. In this work, OS downregulated TGM2 to exert its additive effect with methotrexate and suppress the proliferation, migration, and invasion of RA‐fibroblast‐like synoviocytes (FLS) by attenuating NF‐κB signaling, resulting in the suppression of RA progression. Interestingly, WTAP‐mediated N6‐methyladenosine modification of TGM2 and Myc‐mediated WTAP transcription cooperatively contributed to the formation of a TGM2/Myc/WTAP‐positive feedback loop through upregulating NF‐κB signaling. Moreover, OS could downregulate the activation of the TGM2/Myc/WTAP‐positive feedback circuit. Furthermore, OS restrained the proliferation and polarization of M2 macrophages to inhibit the aggregation of lung interstitial CD11b+ macrophages, and the effectiveness and non‐toxicity of OS in suppressing RA and RA‐ILD progression were verified in vivo. Finally, bioinformatics analyses validated the importance and the clinical significance of the OS‐regulated molecular network. Taken together, our work emphasized OS as an effective drug candidate and TGM2 as a promising target for RA and RA‐ILD treatment.
format Article
id doaj-art-95709f87ad244f398f91fcab65ba3a88
institution Kabale University
issn 2688-2663
language English
publishDate 2023-04-01
publisher Wiley
record_format Article
series MedComm
spelling doaj-art-95709f87ad244f398f91fcab65ba3a882025-01-24T05:36:29ZengWileyMedComm2688-26632023-04-0142n/an/a10.1002/mco2.219Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung diseaseXian Lin0Jian Chen1Cheng Tao2Lianxiang Luo3Juan He4Qingwen Wang5Department of Rheumatism and Immunology Peking University Shenzhen Hospital Shenzhen ChinaDepartment of Rheumatism and Immunology Peking University Shenzhen Hospital Shenzhen ChinaSchool of Pharmacy Guangdong Medical University Dongguan ChinaThe Marine Biomedical Research Institute Guangdong Medical University Zhanjiang ChinaDepartment of Rheumatism and Immunology Peking University Shenzhen Hospital Shenzhen ChinaDepartment of Rheumatism and Immunology Peking University Shenzhen Hospital Shenzhen ChinaAbstract Rheumatoid arthritis (RA) is an inflammatory autoimmune disease, and RA interstitial lung disease (ILD) is a severe complication of RA. This investigation aims to determine the effect and underlying mechanism of osthole (OS), which could be extracted from Cnidium, Angelica, and Citrus plants and evaluate the role of transglutaminase 2 (TGM2) in RA and RA‐ILD. In this work, OS downregulated TGM2 to exert its additive effect with methotrexate and suppress the proliferation, migration, and invasion of RA‐fibroblast‐like synoviocytes (FLS) by attenuating NF‐κB signaling, resulting in the suppression of RA progression. Interestingly, WTAP‐mediated N6‐methyladenosine modification of TGM2 and Myc‐mediated WTAP transcription cooperatively contributed to the formation of a TGM2/Myc/WTAP‐positive feedback loop through upregulating NF‐κB signaling. Moreover, OS could downregulate the activation of the TGM2/Myc/WTAP‐positive feedback circuit. Furthermore, OS restrained the proliferation and polarization of M2 macrophages to inhibit the aggregation of lung interstitial CD11b+ macrophages, and the effectiveness and non‐toxicity of OS in suppressing RA and RA‐ILD progression were verified in vivo. Finally, bioinformatics analyses validated the importance and the clinical significance of the OS‐regulated molecular network. Taken together, our work emphasized OS as an effective drug candidate and TGM2 as a promising target for RA and RA‐ILD treatment.https://doi.org/10.1002/mco2.219interstitial lung diseaseostholerheumatoid arthritisTGM2
spellingShingle Xian Lin
Jian Chen
Cheng Tao
Lianxiang Luo
Juan He
Qingwen Wang
Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
MedComm
interstitial lung disease
osthole
rheumatoid arthritis
TGM2
title Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
title_full Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
title_fullStr Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
title_full_unstemmed Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
title_short Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
title_sort osthole regulates n6 methyladenosine modified tgm2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
topic interstitial lung disease
osthole
rheumatoid arthritis
TGM2
url https://doi.org/10.1002/mco2.219
work_keys_str_mv AT xianlin ostholeregulatesn6methyladenosinemodifiedtgm2toinhibittheprogressionofrheumatoidarthritisandassociatedinterstitiallungdisease
AT jianchen ostholeregulatesn6methyladenosinemodifiedtgm2toinhibittheprogressionofrheumatoidarthritisandassociatedinterstitiallungdisease
AT chengtao ostholeregulatesn6methyladenosinemodifiedtgm2toinhibittheprogressionofrheumatoidarthritisandassociatedinterstitiallungdisease
AT lianxiangluo ostholeregulatesn6methyladenosinemodifiedtgm2toinhibittheprogressionofrheumatoidarthritisandassociatedinterstitiallungdisease
AT juanhe ostholeregulatesn6methyladenosinemodifiedtgm2toinhibittheprogressionofrheumatoidarthritisandassociatedinterstitiallungdisease
AT qingwenwang ostholeregulatesn6methyladenosinemodifiedtgm2toinhibittheprogressionofrheumatoidarthritisandassociatedinterstitiallungdisease